Studies have shown that phosphorylation of AKT and downregulation of PTEN, the negative regulator of this pathway occurs in NSCLC and is related to poor prognosis.35, 36 Downstream activation of this pathway also contributes in resistance to EGF receptor tyrosine kinase inhibitors. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.